TY  - JOUR
A1  - Gorlova, Anna
A1  - Svirin, Evgeniy
A1  - Pavlov, Dmitrii
A1  - Cespuglio, Raymond
A1  - Proshin, Andrey
A1  - Schroeter, Careen A.
A1  - Lesch, Klaus-Peter
A1  - Strekalova, Tatyana
T1  - Understanding the role of oxidative stress, neuroinflammation and abnormal myelination in excessive aggression associated with depression: recent input from mechanistic studies
JF  - International Journal of Molecular Sciences
N2  - Aggression and deficient cognitive control problems are widespread in psychiatric disorders, including major depressive disorder (MDD). These abnormalities are known to contribute significantly to the accompanying functional impairment and the global burden of disease. Progress in the development of targeted treatments of excessive aggression and accompanying symptoms has been limited, and there exists a major unmet need to develop more efficacious treatments for depressed patients. Due to the complex nature and the clinical heterogeneity of MDD and the lack of precise knowledge regarding its pathophysiology, effective management is challenging. Nonetheless, the aetiology and pathophysiology of MDD has been the subject of extensive research and there is a vast body of the latest literature that points to new mechanisms for this disorder. Here, we overview the key mechanisms, which include neuroinflammation, oxidative stress, insulin receptor signalling and abnormal myelination. We discuss the hypotheses that have been proposed to unify these processes, as many of these pathways are integrated for the neurobiology of MDD. We also describe the current translational approaches in modelling depression, including the recent advances in stress models of MDD, and emerging novel therapies, including novel approaches to management of excessive aggression, such as anti-diabetic drugs, antioxidant treatment and herbal compositions.
KW  - major depressive disorder (MDD)
KW  - aggression
KW  - neuroinflammation
KW  - oxidative stress
KW  - insulin receptor
KW  - myelination
Y1  - 2023
U6  - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-304917
SN  - 1422-0067
VL  - 24
IS  - 2
ER  - 
TY  - JOUR
A1  - Rivero, Olga
A1  - Alhama-Riba, Judit
A1  - Ku, Hsing-Ping
A1  - Fischer, Matthias
A1  - Ortega, Gabriela
A1  - Álmos, Péter
A1  - Diouf, David
A1  - van den Hove, Daniel
A1  - Lesch, Klaus-Peter
T1  - Haploinsufficiency of the Attention-Deficit/Hyperactivity Disorder Risk Gene St3gal3 in Mice Causes Alterations in Cognition and Expression of Genes Involved in Myelination and Sialylation
JF  - Frontiers in Genetics
N2  - Genome wide association meta-analysis identified ST3GAL3, a gene encoding the beta-galactosidase-alpha-2,3-sialyltransferase-III, as a risk gene for attention-deficit/hyperactivity disorder (ADHD). Although loss-of-function mutations in ST3GAL3 are implicated in non-syndromic autosomal recessive intellectual disability (NSARID) and West syndrome, the impact of ST3GAL3 haploinsufficiency on brain function and the pathophysiology of neurodevelopmental disorders (NDDs), such as ADHD, is unknown. Since St3gal3 null mutant mice display severe developmental delay and neurological deficits, we investigated the effects of partial inactivation of St3gal3 in heterozygous (HET) knockout (St3gal3±) mice on behavior as well as expression of markers linked to myelination processes and sialylation pathways. Our results reveal that male St3gal3 HET mice display cognitive deficits, while female HET animals show increased activity, as well as increased cognitive control, compared to their wildtype littermates. In addition, we observed subtle alterations in the expression of several markers implicated in oligodendrogenesis, myelin formation, and protein sialylation as well as cell adhesion/synaptic target glycoproteins of ST3GAL3 in a brain region- and/or sex-specific manner. Taken together, our findings indicate that haploinsufficiency of ST3GAL3 results in a sex-dependent alteration of cognition, behavior and markers of brain plasticity.
KW  - sialyltransferase
KW  - sialic acid
KW  - psychiatric disorders
KW  - attention-deficit/hyperactivity disorder (ADHD)
KW  - prefrontal cortex
KW  - hippocampus
KW  - mouse model
Y1  - 2021
U6  - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-246855
SN  - 1664-8021
VL  - 12
ER  -